In addition, other gain- and loss-of-function variants in PLCG2 have recently been linked to a decreased or an increased risk of AD, respectively, which further supports the key role of PLCγ2 in AD and general brain health [13–15]. The gene discussed is PLCG2; the disease is Alzheimer disease.